{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Alpha-Synuclein (α-syn) is a major constituent of Lewy bodies in Parkinson's disease (PD). The A30P mutation in the α-syn gene is associated with rare autosomal dominant forms of familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay, linking the A30P mutation to PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study developed an in vitro assay to characterise the factor(s) involved in α-syn's binding to synaptic membranes, assessing the effects of cytosolic proteins, lipids, ATP, and calcium on the modulation of α-syn membrane association.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (binding assay to synaptic membranes) effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The assay included controls (wild-type and mutant α-syn) and was performed with multiple replicates (n=4 for some conditions).",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were used, meeting the criteria for proceeding to Sub-step 3c.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study compared the membrane binding of A30P α-syn to wild-type and A53T α-syn, showing impaired binding for A30P.",
          "judgment": "Yes",
          "reasoning": "Variant controls (wild-type and A53T α-syn) were used, meeting the criteria for proceeding to Step 4.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper provides statistical analyses showing significant differences in membrane binding between A30P and wild-type/A53T α-syn (One-Way ANOVA, p < 0.0001, n = 4; Bonferroni's multiple comparison test).",
          "judgment": "No",
          "reasoning": "While statistical analyses are provided, there is no direct calculation or reporting of OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study used wild-type and A53T α-syn as controls, totaling 2 variant controls.",
          "judgment": "Yes",
          "reasoning": "The total number of variant controls used is less than 11, indicating a maximum strength of PS3_supporting.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A30P mutation in SNCA shows impaired membrane binding compared to wild-type and A53T α-syn, with the study providing supporting evidence for its pathogenic effect through controlled assays and statistical analyses."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Alpha-Synuclein (α-syn) is a major constituent of Lewy bodies in Parkinson's disease (PD). The A53T mutation in the α-syn gene is associated with rare autosomal dominant forms of familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay, linking the A53T mutation to PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study developed an in vitro assay to characterise the factor(s) involved in α-syn's binding to synaptic membranes, assessing the effects of cytosolic proteins, lipids, ATP, and calcium on the modulation of α-syn membrane association.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (binding assay to synaptic membranes) effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The assay included controls (wild-type and mutant α-syn) and was performed with multiple replicates (n=4 for some conditions).",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were used, meeting the criteria for proceeding to Sub-step 3c.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study compared the membrane binding of A53T α-syn to wild-type and A30P α-syn, showing similar binding to wild-type.",
          "judgment": "Yes",
          "reasoning": "Variant controls (wild-type and A30P α-syn) were used, meeting the criteria for proceeding to Step 4.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper provides statistical analyses showing significant differences in membrane binding between A53T and A30P α-syn (One-Way ANOVA, p < 0.0001, n = 4; Bonferroni's multiple comparison test).",
          "judgment": "No",
          "reasoning": "While statistical analyses are provided, there is no direct calculation or reporting of OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study used wild-type and A30P α-syn as controls, totaling 2 variant controls.",
          "judgment": "Yes",
          "reasoning": "The total number of variant controls used is less than 11, indicating a maximum strength of PS3_supporting.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A53T mutation in SNCA shows similar membrane binding to wild-type α-syn, with the study providing supporting evidence for its pathogenic effect through controlled assays and statistical analyses."
    }
  ]
}